A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

February 28, 2021

Study Completion Date

April 30, 2021

Conditions

Age-related Macular Degeneration

Interventions

DRUG

BAT5906 injection

Signal dose escalation starting from 0.3mg. Route of administration: intravitreal injection

Trial Locations (1)

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing